دورية أكاديمية
أعرض في EDS

Biologic use in hidradenitis suppurativa: patient perspectives and barriers

التفاصيل البيبلوغرافية
العنوان: Biologic use in hidradenitis suppurativa: patient perspectives and barriers
المؤلفون: Devea R. De, Terri Shih, Denise Fixsen, Brindley Brooks, Jennifer L. Hsiao, Vivian Y. Shi
المصدر: Journal of Dermatological Treatment, Vol 33, Iss 7, Pp 3060-3062 (2022)
بيانات النشر: Taylor & Francis Group, 2022.
سنة النشر: 2022
المجموعة: LCC:Dermatology
مصطلحات موضوعية: hidradenitis suppurativa, biologics, patient perspectives, Dermatology, RL1-803
الوصف: Introduction Hidradenitis suppurativa (HS) is an inflammatory dermatosis for which the treatment paradigm is rapidly expanding. We aimed to identify HS patient perspectives and barriers on biologics. Methods An anonymous survey was distributed between 10/2021 and 1/2022 through HS support groups. Data regarding demographics and perspectives on biologics were collected and analyzed. Results Of the 196 respondents, 92% were female (180/196) and 75% were white (147/196). 89.3% had Hurley stage 2/3 HS (102/195). The primary healthcare provider (HCP) for HS in 65% (128/196) of patients was a dermatologist, with 12% (23/196) seen at an HS specialty clinic. Most respondents never tried a biologic medicine (62%, 118/192). The top barriers to biologics were fear of side effects (61%, 109/179), high cost/lack of insurance coverage (46%, 83/179), frequency of weekly injections (32%, 58/179). Respondents reporting their main HCP as a non-dermatologist (4.11 vs 3.0, p
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 0954-6634
1471-1753
09546634
Relation: https://doaj.org/toc/0954-6634; https://doaj.org/toc/1471-1753
DOI: 10.1080/09546634.2022.2089336
URL الوصول: https://doaj.org/article/71cb1cd9699f48458955d25b12051444
رقم الأكسشن: edsdoj.71cb1cd9699f48458955d25b12051444
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:09546634
14711753
DOI:10.1080/09546634.2022.2089336